🟢 Femasys is trading 12.77% up in pre-market after Minnesota Women’s Care adopted two fertility products

Femasys is trading 12.77% up now at $2.89 after Minnesota Women’s Care announced adoption of FemVue and FemaSeed Complete across all four locations.

• The September 15 announcement followed a 4.12% regular-session decline and helped shares rise after hours, according to coverage of the company’s release.
• The partnership expands commercial adoption of Femasys’ fertility portfolio and provides a clear company-specific catalyst for the pre-market move.